# Notice of Intent to Sole Source - FDA_2272025

Canonical: https://abierto.us/opportunities/fda2272025

- Solicitation number: FDA_2272025
- Notice type: Special notice
- Status: Closed. Deadline was March 7, 2025 at 3:00 PM EST
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: Food and Drug Administration (n-FOODANDDRUGADMINISTRATION)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Product or service code: AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside: Total small business set-aside
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: February 28, 2025
- Last posted: February 28, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/59c5885c2cc446e780122994d6ad781b/view

## Description

The Food and Drug Administration (FDA) intends to award a Sole Source Firm Fixed Price contract order to Emulate Bio at 27 Dry Dock Avenue Boston, Massachusetts 02210 In accordance with FAR Part 6.302-1 (a) (2)(ii) which states” Only one responsible source and no other supplies or services will satisfy agency requirement”. The purpose of this notice is to inform the public that the Food and Drug Administration (FDA) anticipates issuing a Firm Fixed Price contract.

**MINIMUM REQUIREMENTS:** See Attached Statement of Work This notice is not a request for competitive proposals. However, any party that believes it can meet this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement. Capability statements must be received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement.

A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. It is anticipated that an award will be issued to Emulate Bio within approximately ten (10) days after the date of this notice unless the Government determines that any other organization has the capability to meet this requirement.

**Response Date:** March 7, 2025, by 3.00PM EST. Please email responses to Hilda Aryeh –hilda.aryeh@fda.hhs.gov.

## Publications

- February 28, 2025: Special notice, due March 7, 2025 at 3:00 PM EST. Notice 59c5885c2cc446e780122994d6ad781b. https://sam.gov/workspace/contract/opp/59c5885c2cc446e780122994d6ad781b/view

## Points of contact

- HILDA ARYEH, hilda.aryeh@fda.hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fda2272025.